2024 Onsite Industry Guide - 18

Innovation Theater
Expanded Schedule
Grab a bite and get informed by attending an Innovation Theater presentation taking place in the
Exhibit Hall. Check the meeting app for the most up-to-date schedule.
THURSDAY, APRIL 18
MORNING BREAK
The Nuts and Bolts of COPD Management in 2024
Supported by: GSK
10:15 - 11:00 a.m. * Theater 1Register Now
Disease education program focused on the fundamentals
of COPD management from diagnosis, assessment,
guideline-based initial treatment as well as follow-up
treatment based on treatment goals of reducing symptoms
and exacerbations, impact of exacerbations on disease
severity, progression and mortality and importance of nonpharmacologic
recommendations including immunizations.
Bartolome Celli, MD ∙ Boston, MA
Expert Perspectives on Stroke Risk Reduction in
NVAF, with a Focus on High-Risk Patient Populations
A Clinical Discussion of an FDA-Approved Oral
Treatment for Adult Patients at High Risk for
Progression to Severe COVID-19
Supported by: Pfizer, Inc.
10:15 - 11:00 a.m. * Theater 2Register Now
Ali Hassoun, MD, FACP, FIDSA, AAHIVS ∙ Huntsville, AL
Shifting the Cancer Screening Paradigm: The Era of
Multi-Cancer Early Detection
Supported by: Exact Sciences
10:15 - 11:00 a.m. * Theater 3Register Now
The multi-cancer early detection (MCED) field is still in
its beginning stages, and it shows great promise as a
fundamentally new approach to screening and detection
of cancer. Learn more about how MCED tests have the
potential to detect more cancers at earlier stages when
they are more treatable.
Michelle Beidelschies, PhD ∙ Madison, WI
Supported by: Johnson & Johnson
12:30 - 1:15 p.m. * Theater 2Register Now
Distinguished presenter will provide expert perspectives
on stroke risk reduction in nonvalvular atrial fibrillation
(NVAF). In addition, this discussion covers NVAF patients
with high-risk features such as obesity, older age, renal
impairment, and prior stroke.
Pamela Kushner, MD, FAAFP ∙ Los Angeles, CA
Navigating RSV in Adults: Insights into Disease and
Vaccination
Supported by: GSK
12:30 - 1:15 p.m. * Theater 3Register Now
Join us to explore the burden of RSV disease in adults, risk
factors for severe disease, and public health implications
of RSV. Experts will also discuss vaccine implementation
following the ACIP's recommendation that adults aged ≥60
years may receive a single dose of an RSV vaccine using
shared clinical decision-making.
Theresa Tolle, BPharm, FAPhA ∙ Sebastian, FL
Barbara Yawn, MD, MSc, MSPH, FAAFP ∙ Rochester, MN
Payel Gupta, MD, FACAAI ∙ Brooklyn, NY
Innovation Theater presentations are independently organized and are not an official part of the Internal Medicine Meeting 2024 Education Program.
18 ONSITE INDUSTRY GUIDE |
Internal Medical Meeting 2024
LUNCH BREAK
Learn How to Dramatically Lower Your Patients
LDL-C and Reduce the Risk of MI, Stroke or Coronary
Revascularization
Supported by: Amgen
12:30 - 1:15 p.m. * Theater 1Register Now
In this presentation we will discuss the new recommendation
from the ACC Expert Consensus Decision Pathway around a
lower LDL-C threshold for patients with ASCVD at very high
risk for CV event.
Javier Morales, MD ∙ Greenvale, NY

2024 Onsite Industry Guide

Table of Contents for the Digital Edition of 2024 Onsite Industry Guide

2024 Onsite Industry Guide - A
2024 Onsite Industry Guide - 1
2024 Onsite Industry Guide - 2
2024 Onsite Industry Guide - 3
2024 Onsite Industry Guide - 4
2024 Onsite Industry Guide - 5
2024 Onsite Industry Guide - 6
2024 Onsite Industry Guide - 7
2024 Onsite Industry Guide - 8
2024 Onsite Industry Guide - 9
2024 Onsite Industry Guide - 10
2024 Onsite Industry Guide - 11
2024 Onsite Industry Guide - 12
2024 Onsite Industry Guide - 13
2024 Onsite Industry Guide - 14
2024 Onsite Industry Guide - 15
2024 Onsite Industry Guide - 16
2024 Onsite Industry Guide - 17
2024 Onsite Industry Guide - 18
2024 Onsite Industry Guide - 19
2024 Onsite Industry Guide - 20
2024 Onsite Industry Guide - 21
2024 Onsite Industry Guide - 22
2024 Onsite Industry Guide - 23
2024 Onsite Industry Guide - 24
2024 Onsite Industry Guide - 25
2024 Onsite Industry Guide - 26
2024 Onsite Industry Guide - 27
2024 Onsite Industry Guide - 28
2024 Onsite Industry Guide - 29
2024 Onsite Industry Guide - 30
2024 Onsite Industry Guide - 31
2024 Onsite Industry Guide - 32
2024 Onsite Industry Guide - 33
2024 Onsite Industry Guide - 34
2024 Onsite Industry Guide - 35
2024 Onsite Industry Guide - 36
2024 Onsite Industry Guide - 37
2024 Onsite Industry Guide - 38
2024 Onsite Industry Guide - 39
2024 Onsite Industry Guide - 40
2024 Onsite Industry Guide - 41
2024 Onsite Industry Guide - 42
2024 Onsite Industry Guide - 43
https://www.nxtbookmedia.com